foxo4-dri senolytic mice baar 2017 10mg FOXO4-DRI 10mg vial - Description
FOXO4 DRI 10mg vial Description RCpeptides Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



00300-7/asset/fc51add5-22b1-4645-9507-e89d0738c67a/main.assets/gr1_lrg.jpg)